Newark, Delaware, United States
AstraZeneca Newark Transformation
Lendlease managed AstraZeneca's (AZ) multi-phased Newark Facility Transformation (NFT) project in Newark, Delaware consisting of the construction of a new oral solid dosage (OSD) formulation suite, and renovations and upgrades to the facility's packaging lines, warehouse and support areas.
Project outcome
All work was performed while the facility remains fully operational. In March 2016, the Lendlease NFT project team, was awarded a 'Gold Star Safety' at AstraZeneca's Global Engineering's North America Safety awards ceremony.